Type I Interferons in Host Defense

Immunity

Volumn 25, Issue 3, 2006, Pages 373-381

  Stetson, Daniel B ^a   Medzhitov, Ruslan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOL RECEPTOR; INTERFERON; TOLL LIKE RECEPTOR; VIRUS ANTIGEN; VIRUS VACCINE;

ANTIVIRAL ACTIVITY; APOPTOSIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INNATE IMMUNITY; INTERFERON INDUCTION; LYMPHOCYTE ACTIVATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE I; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 33748455338     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.08.007     Document Type: Review

References (83)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
3. Arnheiter H., Skuntz S., Noteborn M., Chang S., and Meier E. Transgenic mice with intracellular immunity to influenza virus. Cell 62 (1990) 51-61
4. Auerbuch V., Brockstedt D.G., Meyer-Morse N., O'Riordan M., and Portnoy D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200 (2004) 527-533
5. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., and Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 (2000) 129-141
6. Balachandran S., Thomas E., and Barber G.N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432 (2004) 401-405
7. Banchereau J., and Pascual V. Type I interferon in sytemic lupus erythematosus and other autoimmune diseases. Immunity 25 (2006) 383-392 this issue
8. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7 (2006) 49-56
9. Carrero J.A., Calderon B., and Unanue E.R. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200 (2004) 535-540
10. Carrero J.A., Calderon B., and Unanue E.R. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203 (2006) 933-940
11. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., and Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435 (2005) 108-114
12. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 (2004) 1219-1226
13. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
14. Fisher A.G., Ensoli B., Ivanoff L., Chamberlain M., Petteway S., Ratner L., Gallo R.C., and Wong-Staal F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237 (1987) 888-893
15. Foy E., Li K., Wang C., Sumpter Jr. R., Ikeda M., Lemon S.M., and Gale Jr. M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
16. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W.A., and Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66 (1992) 6489-6495
17. Garcia-Sastre A., and Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 (2006) 879-882
18. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., Diamond M.S., and Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103 (2006) 8459-8464
19. Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G.B., and Wagner H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17 (1998) 6230-6240
20. Harding H.P., Calfon M., Urano F., Novoa I., and Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18 (2002) 575-599
21. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 113 (2003) 803-809
22. Heil F., Ahmad-Nejad P., Hemmi H., Hochrein H., Ampenberger F., Gellert T., Dietrich H., Lipford G., Takeda K., Akira S., et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33 (2003) 2987-2997
23. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
24. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
25. Hess C.B., Niesel D.W., Cho Y.J., and Klimpel G.R. Bacterial invasion of fibroblasts induces interferon production. J. Immunol. 138 (1987) 3949-3953
26. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
27. Honda K., Yanai H., Takaoka A., and Taniguchi T. Regulation of the type I IFN induction: a current view. Int. Immunol. 17 (2005) 1367-1378
28. Honda K., Takaoka A., and Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 (2006) 349-360 this issue
29. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 258-267
30. Isaacs A., Lindenmann J., and Valentine R.C. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 268-273
31. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
32. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
33. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (1989) 1-13
34. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., and Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
35. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
36. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
37. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
38. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., and Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202 (2005) 637-650
39. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., and Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
40. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., and Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103 (2004) 1433-1437
41. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., and Akira S. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203 (2006) 1795-1803
42. Le Bon A., Etchart N., Rossmann C., Ashton M., Hou S., Gewert D., Borrow P., and Tough D.F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4 (2003) 1009-1015
43. Lee C.K., Rao D.T., Gertner R., Gimeno R., Frey A.B., and Levy D.E. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165 (2000) 3571-3577
44. Lee H.K., Dunzendorfer S., Soldau K., and Tobias P.S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24 (2006) 153-163
45. Levy D.E., Marie I., and Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15 (2003) 52-58
46. Loo Y.M., Owen D.M., Li K., Erickson A.K., Johnson C.L., Fish P.M., Carney D.S., Wang T., Ishida H., Yoneyama M., et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 103 (2006) 6001-6006
47. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198 (2003) 513-520
48. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101 (2004) 5598-5603
49. Madani N., and Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72 (1998) 10251-10255
50. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
51. McWhirter S.M., Tenoever B.R., and Maniatis T. Connecting mitochondria and innate immunity. Cell 122 (2005) 645-647
52. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
53. Nagano Y., and Kojima Y. Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus. C. R. Seances Soc. Biol. Fil. 152 (1958) 1627-1629
54. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25 (2000) 177-181
55. Newman E.N., Holmes R.K., Craig H.M., Klein K.C., Lingappa J.R., Malim M.H., and Sheehy A.M. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15 (2005) 166-170
56. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., and Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169 (2002) 4279-4287
57. Nguyen K.B., Watford W.T., Salomon R., Hofmann S.R., Pien G.C., Morinobu A., Gadina M., O'Shea J.J., and Biron C.A. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297 (2002) 2063-2066
58. Nimchuk Z., Eulgem T., Holt III B.F., and Dangl J.L. Recognition and response in the plant immune system. Annu. Rev. Genet. 37 (2003) 579-609
59. O'Connell R.M., Saha S.K., Vaidya S.A., Bruhn K.W., Miranda G.A., Zarnegar B., Perry A.K., Nguyen B.O., Lane T.F., Taniguchi T., et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200 (2004) 437-445
60. O'Connell R.M., Vaidya S.A., Perry A.K., Saha S.K., Dempsey P.W., and Cheng G. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J. Immunol. 174 (2005) 1602-1607
61. O'Riordan M., Yi C.H., Gonzales R., Lee K.D., and Portnoy D.A. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. USA 99 (2002) 13861-13866
62. Okabe Y., Kawane K., Akira S., Taniguchi T., and Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202 (2005) 1333-1339
63. Oshiumi H., Matsumoto M., Funami K., Akazawa T., and Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4 (2003) 161-167
64. Pavlovic J., Schroder A., Blank A., Pitossi F., and Staeheli P. Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found. Symp. 176 (1993) 233-243
65. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
66. Schulz O., Diebold S.S., Chen M., Naslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.T., Flavell R.A., Liljestrom P., and Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433 (2005) 887-892
67. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., and McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 21 (2003) 377-423
68. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005) 669-682
69. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
70. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
71. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
72. Stockinger S., Reutterer B., Schaljo B., Schellack C., Brunner S., Materna T., Yamamoto M., Akira S., Taniguchi T., Murray P.J., et al. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J. Immunol. 173 (2004) 7416-7425
73. Sun Q., Sun L., Liu H.H., Chen X., Seth R.B., Forman J., and Chen Z.J. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 (2006) 633-642
74. Sverdlov E.D. Retroviruses and primate evolution. Bioessays 22 (2000) 161-171
75. Takaoka A., Hayakawa S., Yanai H., Stoiber D., Negishi H., Kikuchi H., Sasaki S., Imai K., Shibue T., Honda K., and Taniguchi T. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424 (2003) 516-523
76. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
77. van Boxel-Dezaire A.H.H., Rani M.R.S., and Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25 (2006) 361-372 this issue
78. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19 (2005) 727-740
79. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., and Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169 (2002) 6668-6672
80. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., and Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395 (1998) 284-288
81. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
82. Yoshida H., Okabe Y., Kawane K., Fukuyama H., and Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6 (2005) 49-56
83. Zhang X., Sun S., Hwang I., Tough D.F., and Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8 (1998) 591-599